Symptom experience during the late reproductive stage and the menopausal transition: observations from the Women Living Better survey.
Journal
Menopause (New York, N.Y.)
ISSN: 1530-0374
Titre abrégé: Menopause
Pays: United States
ID NLM: 9433353
Informations de publication
Date de publication:
26 07 2021
26 07 2021
Historique:
pubmed:
28
7
2021
medline:
21
10
2021
entrez:
27
7
2021
Statut:
epublish
Résumé
The aim of this study was to examine the occurrence of a variety of symptoms, their frequency, bother, burden, and interference in the lives of women in the late reproductive stage (LRS) and compare their experiences to that of women in the menopausal transition (MT) stage. Women ages 35 to 55 years responded to an 82-question online survey offered by Women Living Better. Participants reported current menstrual patterns, recent changes and symptom frequency, bother, and interference. Women's cycles were classified as LRS or MT using Stages of Reproductive Aging Workshop +10 criteria. Of 2,406 respondents, 946 met criteria for LRS and 583 for MT. Participants included 30% from outside the United States, 31% from diverse racial/ethnic groups, and 18% reported having difficulty paying for basics. A similar proportion of women in the LRS and MT+ groups reported each of the symptoms: there was a less than 10% difference for 54 of the 61 symptoms. Of mean bother ratings for all symptoms, only hot flashes differed significantly between the LRS and MT groups. LRS women experienced similar levels of symptom-related interference with personal relationships and daily living to those in the MT stage but did not anticipate these symptoms occurring until they were 50 years old. Women in the LRS experience symptoms strikingly similar to those often associated with the MT. Women do not expect these changes until the age of 50 years or later and are surprised by such symptoms before cycle irregularity. Research about the epidemiology and management of LRS symptoms, anticipatory guidance for women, and education for clinicians who care for them warrant increased attention.
Identifiants
pubmed: 34313615
doi: 10.1097/GME.0000000000001805
pii: 00042192-202109000-00006
pmc: PMC8549458
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1012-1025Informations de copyright
Copyright © 2021 by The North American Menopause Society.
Déclaration de conflit d'intérêts
Financial disclosures/conflicts of interest: None reported.
Références
Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001; 76:874–878.
Harlow SD, Gass M, Hall JE, et al. STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 2012; 97:1159–1168.
Woods NF, Mitchell ES, Coslov ND, Richardson MK. Transitioning to the menopausal transition: a scoping review of research on the late reproductive stage in reproductive aging. Menopause 2021; 28:447–466.
Cray LA, Woods NF, Herting JR, Mitchell ES. Symptom clusters during the late reproductive stage through the early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause 2012; 19:864–869.
Jones HJ, Huang AJ, Subak LL, Brown JS, Lee KA. Bladder symptoms in the early menopausal transition. J Womens Health (Larchmt) 2016; 25:457–463.
Woods NF, Mitchell ES. Consequences of incontinence for women during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause 2013; 20:915–921.
Weber MT, Rubin LH, Maki PM. Cognition in perimenopause: the effect of transition stage. Menopause 2013; 20:511–517.
Jurczak A, Szkup M, Grzywacz A, Safranow K, Grochans E. The analysis of anxiety and mood in healthy late-reproductive-stage women with regard to hormonal and genetic factors. Arch Womens Ment Health 2016; 19:1141–1148.
Mitchell ES, Woods NF, Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause 2000; 7:334–349.
Dennerstein L, Dudley E, Hopper J, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000; 96:351–358.
Mitchell ES, Woods NF. Symptom experiences of midlife women: observations from the Seattle Midlife Women's Health Study. Maturitas 1996; 25:1–10.
Woods NF, Mitchell ES. The Seattle Midlife Women's Health Study: a longitudinal prospective study of women during the menopausal transition and early postmenopause. Womens midlife health 2016; 2:6.
Freeman EW, Sammel MD, Liu L, Martin P. Psychometric properties of a menopausal symptom list. Menopause 2003; 10:258–265.
Freeman EW, Sammel MD. Methods in a longitudinal cohort study of late reproductive age women: the Penn Ovarian Aging Study (POAS). Womens Midlife Health 2016; 2:1.
Newton KM, Carpenter JS, Guthrie KA, et al. Methods for the design of vasomotor symptom trials: the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health network. Menopause 2014; 21:45–58.
Woods NF, Hohensee C, Carpenter JS, et al. Symptom clusters among MsFLASH clinical trial participants. Menopause 2016; 23:158–165.
Gapstur RL. Symptom burden: a concept analysis and implication for oncology nurses. Oncology Nursing Forum 2007; 34:673–680.
Loprinzi L, Barton DL, Sloan JA, et al. Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc 2002; 77:1159–1163.
Carpenter JS. The hot flash related daily interference scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 2001; 22:979–989.
Ruble DN, Brooks-Gunn J. The experience of menarche. Child Dev 1982; 53:1557–1566.
Lennon MC. The psychological consequences of menopause: The importance of timing of a strange life event. J Health Soc Behav 1982; 23:353–366.
Gracia CR, Sammel MD, Freeman EW, et al. Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause 2005; 12:128–135.
Freeman EW, Sammel MD, Lin H, et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 2007; 110:230–240.
Mitchell ES, Woods NF. Hot flush severity during the menopausal transition and early postmenopause: beyond hormones. Climacteric 2015; 18:536–544.
Woods NF, Mitchell ES, Adams C. Memory functioning among midlife women: observations from the Seattle Midlife Women's Health Study. Menopause 2000; 7:257–265.
Mitchell ES, Woods NF. Pain symptoms during the menopausal and early postmenopause: observations from the Seattle Midlife Women's Health Study. Climacteric 2010; 13:467–478.
Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S. Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet Gynecol 2008; 111:127–136.
Hollander LE, Freeman EW, Sammel MD, Berlin JA, Grisso JA, Battistini M. Sleep quality, estradiol levels, and behavioral factors in late reproductive age women. Obstet Gynecol 2001; 98:391–397.
Woods NF, Mitchell ES. Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Sleep 2010; 33:539–549.
Freeman EW, Sammel MD, Liu H, Gracia CR, Nelson DB, Hollander BA. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004; 61:62–70.
Mitchell ES, Woods NF. Depressed mood during the menopausal transition: is it reproductive aging or is it life? Womens Midlife Health 2017; 3:11.
Woods NF, Smith-diJulio K, Percival DB, Tao EY, Mariella A, Mitchell S. Depressed mood during the menopausal transition and early postmenopause: Observations from the Seattle Midlife Women's Health Study. Menopause 2008; 15:223–232.
Mitchell ES, Woods NF. Correlates of urinary incontinence during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Climacteric 2013; 16:653–662.
Younis JS, Iskander R, Fauser BCJM, Izhaki I. Does an association exist between menstrual cycle length within the normal range and ovarian reserve biomarkers during the reproductive years? A systematic review and meta-analysis. Hum Reprod Update 2020; 26:904–928.
Finkelstein JS, Lee H, Karlamangla A, et al. Antimullerian hormone and impending menopause in late reproductive age: the study of women's health across the nation. J Clin Endocrinol Metab 2020; 105:e1862–e1871.
Fredericksen B, Gomez I, Sagalnicoff A, Ranji U. Coronavirus: a look at gender differences in awareness and actions. The Henry J Kaiser Family Foundation. Available at: https://www.kff.org/womens-health-policy/issue-brief/coronavirus- a-look-at-gender-differences-in awareness-and-actions/ . Accessed February 22, 2021.